HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Health OTC Drugs Retail

Zur Rose’s Experiment In Automated Pharmacy Shut Down For A Second Time

  • News

Executive Summary

Swiss supply chain disruptor Zur Rose's DocMorris-branded automated pharmacy continues to fall foul of the German legal system.

You may also be interested in...



OTC Vending Machines? Meet Zur Rose’s Latest Experiment In Automated Pharmacy

As well as trying to become the Amazon of European healthcare, Swiss supply chain distruptor Zur Rose continues to experiment with automated pharmacy models with an OTC vending machine in Kirchberg.

Zur Rose Steams Ahead With Acquisition-Led Expansion Amid Investor Concerns

Zur Rose adds French online retail platform Doctipharma as two board members resign over “differences of opinion” with regards to the firm's growth strategy.

Zur Rose’s European playpen

As Switzerland-based e-commerce pharmacy Zur Rose goes from strength to strength, David Ridley talks to the company’s chief executive officer, Walter Oberhänsli, about his firm’s latest experiments in European OTC market disruption.

Table

View full table

Related Content

HBW Insight

Topics

Tags:
Health OTC Drugs Retail
Latest Headlines

Cosmetic And Personal Care Trademark Review: 16 April

Health And Wellness Weekly Trademarks Review: 16 April

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Prestige Expands UK Eye Care Range In Response To Consumer Demand

See All
UsernamePublicRestriction

Register

RS148709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By